Acute Ischemia Monitors Market Size Worth $2.77 Billion by 2027; Top Key Players: Boston Scientific Corp, Medtronic plc, Angel Medical Systems Inc., etc | Reports and Data

 Breaking News
  • No posts were found

Acute Ischemia Monitors Market Size Worth $2.77 Billion by 2027; Top Key Players: Boston Scientific Corp, Medtronic plc, Angel Medical Systems Inc., etc | Reports and Data

February 11
23:26 2021
Acute Ischemia Monitors Market Size Worth $2.77 Billion by 2027; Top Key Players: Boston Scientific Corp, Medtronic plc, Angel Medical Systems Inc., etc | Reports and Data
The surging prevalence of acute ischemia and the emergence of advanced medical equipment for heart diseases boost the growth of this market

Market Size – USD 1.51 billion in 2019, Market Growth – CAGR of 7.5%, Market Trends –Technological advancements in healthcare infrastructure

 The global acute ischemia monitors market is expected to be valued at USD 2.77 Billion in 2027 from USD 1.51 Billion in 2019, registering a CAGR of 7.5% through the forecast period. Acute ischemia refers to a sudden significant reduction in blood flow, mostly caused due to gradually decreasing blood flow. The condition most often leads to severe heart attack and stroke. Acute ischemia monitors are electrogram devices that record cardiac data and help detect ischemic events. One of the primary purposes of these devices is to provide an individual with an early warning of an ischemic event.

 Prominent market players are Boston Scientific Corp, Medtronic plc, Angel Medical Systems Inc., Alfred Health Victoria Company, Cardiowatch Ltd., Blue Box Health Inc., Flashback Technologies, Inc., NewCardio, Inc., Intersection Medical, Inc., and Scivanta Medical Corp.

 To Get Sample Copy of Report visit:

 The global acute ischemia monitors market is expected to account for a substantially high revenue in the forthcoming years, owing to various favorable factors. The primary factors contributing to the growth of the global market include the surging incidences of acute ischemic events, rising prevalence of heart disorders, the introduction of advanced equipment for heart diseases, and technological advancements in ischemia monitors, such as portable, insertable, implantable ischemia monitors. The increasing mortality rates due to acute ischemia, rising adoption of state-of-the-art cardiac monitoring devices, growing awareness about health and fitness, and increased government funding for healthcare infrastructure development are the other crucial parameters propelling the global acute ischemia monitors market growth.

Key findings from the report:

  • Of the various device types, the benchtop monitors sub-segment is expected to lead the global acute ischemia monitors market over the forecast period. The segment is projected to accumulate a significant USD 1.35 Billion by 2027, displaying a robust CAGR of 7.7% through the estimated period. A considerable rise in cardiac surgical procedures, increasing incidences of acute ischemia, and rising installation across hospitals and surgical centers worldwide are the key factors bolstering this sub-segment’s growth. However, the portable monitors sub-segment would exhibit the highest CAGR of 9.1% over the forecast timeline, owing to the rise in ambulatory surgical procedures and growing adoption of first-aid care for heart attacks and stroke.
  • Based on application, the surgical intervention segment is estimated to accrue around USD 725.95 million over the projected period at an impressive CAGR of 8.1%. A rapid surge in cardiac surgical procedures worldwide, the rising prevalence of cardiovascular diseases, and favorable medical reimbursement policies for heart strokes have stimulated the growth of this segment.  
  • The Asia Pacific region is expected to record a robust 8.4% CAGR over the forecast period, securing the leading position in the global acute ischemia monitors market. The growing prevalence of cardiovascular diseases, the emergence of technologically advanced ischemia monitors, a boom in medical tourism, and remarkable developments in healthcare infrastructure over recent years are the pivotal factors expected to trigger the regional market growth.
  • In August 2020, the Indian pharmaceutical major Cipla, in collaboration with Stempeutics Research, introduced India’s first-ever allogeneic cell therapy product, called Stempeucel®, for critical limb ischemia (CLI) treatment. Reportedly, the latest launch followed the commercial use approval by the Drug Controller General of India (DCGI) for the new product.

Read More @

For the purpose of this study, the global acute ischemia monitors market has been segmented on the basis of device type, application, and region:

By Device Type (Revenue, USD Million; 2017-2027)

  • Portable
  • Benchtop
  • Implantable/Insertible

By Application (Revenue, USD Million; 2017-2027)

  • Initial management
  • Surgical recovery
  • Surgical intervention
  • Emergency room
  • Critical care
  • Long-term care

By Region (Revenue, USD Million; 2017-2027)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Content :

 Chapter 1. Market Synopsis

   1.1. Market Definition
   1.2. Research Scope & Premise
   1.3. Methodology
   1.4. Market Estimation Technique
Chapter 2. Executive Summary
   2.1. Summary Snapshot, 2018-2026
Chapter 3. Indicative Metrics
   3.1. Macro Indicators
          3.1.1. Global usage of Fall Protections
          3.1.2. Global Fall Protections usage by Application Type
Chapter 4. Global Acute Ischemia Monitors Market Segmentation & Impact Analysis
   4.1. Global Acute Ischemia Monitors Segmentation Analysis
   4.2. Global Acute Ischemia Monitors Market Value Chain Analysis, 2018-2026
   4.3. Regulatory framework
   4.4. Global Acute Ischemia Monitors Market Impact Analysis
          4.4.1. Market driver analysis
          4.4.2. Market restraint analysis
   4.5. Key opportunities prioritized
   4.6. Types analysis – Porter’s
   4.7. Global Acute Ischemia Monitors Competitive scenario, 2018



 Find more research reports on Pharma and Healthcare Industry, by Reports And Data:

 Acute Myeloid Leukemia Therapeutics Market Size, Share and Analysis By Regimen (DC Regimen, AVD Regimen, VCD Regimen), By Treatment (Chemotherapy, Radiation therapy, Stem Cell Transplant, Targeted Therapy) And By End-user (Hospital, Retails Drug Stores, Ambulatory Care Centers, Clinics), Forecasts To 2027

 Acute Respiratory Distress Syndrome (ARDS) Market Analysis, By Device Type (Monitoring Devices, Diagnostic Devices, Therapeutic Devices), By Injury (Brain, Lung), By Severity (Mild, Moderate, Severe), By Treatment (Fibro Proliferate, Exudative, Resolution, Recovery), By Sales Channel (Direct Sales, Channel Sales), By End-User (Hospitals, Clinics, Ambulatory Service Centers, Others), By Region, Forecasts To 2027

 Thank you for reading our report. For more details on the report or to inquire about customization options, please let us know. We will offer you a report well-suited to your needs.

 About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States

Related Articles